C. Muller-Serieys

发表

Multicenter Evaluation of an Automated System Using Selected Bacteria That Harbor Challenging and Clinically Relevant Mechanisms of Resistance to Antibiotics

P. Nordmann, H. Chardon, R. Leclercq, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Pseudomonas aeruginosa post-operative peritonitis: clinical features, risk factors, and prognosis.

P. Woerther, P. Montravers, C. Muller-Serieys, 2013, Surgical infections.

Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

S. Lasocki, P. Montravers, A. Andremont, 2010, Journal of medical microbiology.

Dirithromycin Concentrations in Bronchial Mucosa and Secretions

D. Benhamou, C. Muller-Serieys, C. Leroyer, 1998, Respiration.

Intrapulmonary Pharmacokinetics of Telithromycin, a New Ketolide, in Healthy Japanese Volunteers

C. Muller-Serieys, S. Kohno, K. Tomono, 2002, Antimicrobial Agents and Chemotherapy.

Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients

C. Muller-Serieys, P. Soler, M. Aubier, 1992, Antimicrobial Agents and Chemotherapy.

Tissue kinetics of telithromycin, the first ketolide antibacterial.

F. Vacheron, C. Muller-Serieys, J. Andrews, 2004, The Journal of antimicrobial chemotherapy.

Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

D. Le Guludec, Y. Petegnief, B. Fantin, 2003, Antimicrobial Agents and Chemotherapy.

Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection

C. Muller-Serieys, A. Crémieux, L. Massias, 2002, Antimicrobial Agents and Chemotherapy.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

R. Leclercq, P. Legrand, C. Muller-Serieys, 2011, International journal of antimicrobial agents.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints

L. Armand-Lefèvre, R. Leclercq, P. Legrand, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Rapid adaptation of antibiotic therapy for community-acquired peritonitis using direct cultures on antibiotic agar plates: pilot study.

S. Lasocki, P. Montravers, A. Andremont, 2009, Surgical infections.

Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy

C. Muller-Serieys, M. Aubier, E. Bergogne-Bérézin, 2004, European Journal of Clinical Pharmacology.

Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients

C. Muller-Serieys, E. Bergogne-Bérézin, H. Monteil, 1994, Antimicrobial Agents and Chemotherapy.

Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus

C. Muller-Serieys, A. Crémieux, A. Dinh, 2011, Antimicrobial Agents and Chemotherapy.

Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647)

Antoine Andremont, A. Andremont, C. Muller-Serieys, 2001, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study

M. Kempf, C. Muller-Serieys, J. Maugein, 2010, BMC infectious diseases.

An Outbreak of Imipenem-Resistant Acinetobacter baumannii in Critically Ill Surgical Patients

J. Lucet, J. Mantz, C. Muller-Serieys, 2001, Infection Control & Hospital Epidemiology.

Bactericidal Activity of the Combination of Levofloxacin with Rifampin in Experimental Prosthetic Knee Infection in Rabbits Due to Methicillin-Susceptible Staphylococcus aureus

B. Fantin, C. Muller-Serieys, L. Massias, 2009, Antimicrobial Agents and Chemotherapy.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

R. Leclercq, C. Muller-Serieys, J. Etienne, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.

C. Muller-Serieys, E. Bergogne-Bérézin, H. Kafé, 1992, The American journal of medicine.

Development of a Phenotypic Method for Detection of Fecal Carriage of OXA-48-Producing Enterobacteriaceae after Incidental Detection from Clinical Specimen

M. Marre, J. Lucet, E. Ruppé, 2011, Journal of Clinical Microbiology.

Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome.

H. Goossens, J. Mantz, H. Dupont, 2008, Diagnostic microbiology and infectious disease.

Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis

S. Lasocki, P. Montravers, C. Muller-Serieys, 2010, Critical care.

Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients.

J. Mantz, H. Dupont, C. Muller-Serieys, 2002, Archives of surgery.

Native valve endocarditis due to Corynebacterium striatum: first reported case of medical treatment alone.

Claude Carbón, C. Muller-Serieys, P. Tattevin, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emergence of carbapenem-resistant Hafnia: the fall of the last soldier.

S. Lasocki, P. Montravers, A. Andremont, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Fosfomycin Trometamol (Monuril) in Healthy Volunteers

C. Muller-Serieys, E. Bergogne-Bérézin, 1988 .

Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.

C. Muller-Serieys, E. Bergogne-Bérézin, M. Joly-Guillou, 1987, European urology.

Activity of beta-lactamase inhibitor combinations onEscherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents

B. Picard, C. Muller-Serieys, E. Bergogne-Bérézin, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[Present status of nitroxoline].

C. Muller-Serieys, E. Bergogne-Bérézin, G. Berthelot, 1987, Pathologie-biologie.

[Epidemiology of resistance to antibiotics in respiratory tract infections].

C. Muller-Serieys, 1999, Presse medicale.

[Nosocomial infections caused by Acinetobacter. Epidemiology and therapeutic difficulties].

C. Muller-Serieys, E. Bergogne-Bérézin, M. Joly-Guillou, 1989, Presse medicale.

Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates.

Claude Carbón, C. Muller-Serieys, D. Decré, 1999, The Journal of antimicrobial chemotherapy.

Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments

X. Panhard, A. Andremont, C. Muller-Serieys, 2003, Antimicrobial Agents and Chemotherapy.